Bayban’s Gilead Sciences GILD Stock Holding History

Bayban’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111K	Hold	879	–	–	0.09%	154
2026 Q1	$123K	Hold	879	–	–	0.11%	143
2025 Q4	$108K	Buy	+879	New	+$107K	0.1%	157

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bayban's GILD Position: Q2 2026 in Review

Bayban held its Gilead Sciences (GILD) position steady in Q2 2026 at 879 shares worth $111K. The position accounts for 0.09% of the portfolio, ranked #154.

Bayban first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $123K in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Bayban held 879 shares of Gilead Sciences worth $111K as of Q2 2026.
Bayban left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.09% of Bayban's portfolio in Q2 2026, its #154 holding.
Bayban first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
Bayban's Gilead Sciences position peaked at $123K in Q1 2026.
2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.